← Papers

Paper record

Bioassays to Evaluate the Resistance of Whole Plants to the Herbivorous Insect Thrips.

Steenbergen M, Broekgaarden C, Pieterse CMJ, Van Wees SCM.

Methods in molecular biology (Clifton, N.J.) · 1 Jan 2020 · 10.1007/978-1-0716-0142-6_7

Abstract

Thrips are tiny, cell-content-feeding insects that are a major pest on crops and ornamentals. Besides causing direct feeding damage, thrips may also cause indirect damage by vectoring tospoviruses. Novel resistance mechanisms to thrips need to be discovered and validated. Induction of jasmonic acid-dependent defenses has been demonstrated to be essential for resistance to thrips, but underlying mechanisms still need to be discovered. For this, it is vital to use robust plant-thrips assays to analyze plant defense responses and thrips performance. In recently developed high-throughput phenotyping platforms, the feeding damage that is visible as silver spots, and the preference of thrips in a two-choice setup is assessed, using leaf discs. Here, we describe whole-plant thrips assays that are essential for (1) validation of findings obtained by the leaf disc assays, (2) assessment of longer-term effects on thrips feeding success and fecundity, (3) determination of spatial-temporal effects induced by primary thrips infestation on a secondary attack by thrips or other insects or pathogens, and (4) assessment of gene expression and metabolite changes. We present detailed methods and tips and tricks for (a) rearing and selection of thrips at different developmental stages, (b) treatment of the whole plant or an individual leaf with thrips, and (c) determination of feeding damage and visualization of thrips oviposition success in leaves.

Code and data availability

This is a methods/protocol chapter describing whole-plant thrips bioassays. The supplied blocks contain no public phenotype/trait datasets, plant images, sensor/3D inputs, author analysis code, trained models, or supplements with such assets. References to high-throughput phenotyping platforms and freeware (refs 8, 9),

No evidence-backed public reproduction asset is currently recorded.